| |
|
|
|
|
|
|
|||
|
Blood, 1 February 2005, Vol. 105, No. 3, pp. 921-923. Prepublished online as a Blood First Edition Paper on October 5, 2004; DOI 10.1182/blood-2004-06-2404.
PERSPECTIVES A case for developing North-South partnerships for research in sickle cell diseaseFrom the Weatherall Institute of Molecular Medicine, University of Oxford, United Kingdom; Fogarty International Center, National Institutes of Health, Bethesda, MD; Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD; and National Center for Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD.
Abstract For a better understanding of the pathophysiology and mechanisms of phenotypic diversity of sickle cell disease, and for the improvement of its management globally, there is a strong case for developing sustainable research partnerships between rich and poor countries.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||